參考文獻 |
1.Asai Y, Yanishevsky Y, Clarke A, et al. Rate, triggers, severity and management of anaphylaxis in adults treated in a Canadian emergency department. Int Arch Allergy Immunol. 2014;164(3):246-252.
2.Golden DB. Anaphylaxis to insect stings. Immunol Allergy Clin North Am. 2015;35(2):287-302.
3.Storey P, Fitzharris P. Adrenaline in anaphylaxis: overtreatment in theory, undertreatment in reality. Postgraduate medical journal. 2015;91(1071):1-2.
4.Worm M, Eckermann O, Dolle S, et al. Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland. Dtsch Arztebl Int. 2014;111(21):367-375.
5.Poziomkowska-Gesicka I, Kurek M. Clinical Manifestations and Causes of Anaphylaxis. Analysis of 382 Cases from the Anaphylaxis Registry in West Pomerania Province in Poland. Int J Environ Res Public Health. 2020;17(8).
6.Bilo MB. Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment. Allergy. 2011;66 Suppl 95:35-37.
7.Bilo BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN, Hypersensitivity EIGoIV. Diagnosis of Hymenoptera venom allergy. Allergy. 2005;60(11):1339-1349.
8.Tankersley MS. The stinging impact of the imported fire ant. Curr Opin Allergy Clin Immunol. 2008;8(4):354-359.
9.Pesek RD, Lockey RF. Management of insect sting hypersensitivity: an update. Allergy Asthma Immunol Res. 2013;5(3):129-137.
10.Bertelsmeier C, Luque G, Hoffmann B, Courchamp F. Worldwide ant invasions under climate change. Biodiversity and Conservation. 2014;24.
11.Visitsunthorn N, Kijmassuwan T, Visitsunthorn K, Pacharn P, Jirapongsananuruk O. Clinical Characteristics of Allergy to Hymenoptera Stings. Pediatr Emerg Care. 2017.
12.Adkinson NF, Bochner BS, Burks AW, et al. Middleton′s allergy : principles and practice. 8th ed. USA: Elsevier; 2014.
13.Central Weather Bureau Taipei 10048, Taiwan (R.O.C.). https://www.cwb.gov.tw/eng/.
14.Kemp SF, deShazo RD, Moffitt JE, Williams DF, Buhner WA, 2nd. Expanding habitat of the imported fire ant (Solenopsis invicta): a public health concern. J Allergy Clin Immunol. 2000;105(4):683-691.
15.McCubbin KI, Weiner JM. Fire ants in Australia: a new medical and ecological hazard. Med J Aust. 2002;176(11):518-519.
16.Johnny S. C. Chen C-HS, How-Jing Lee. Monogynous and Polygynous Red Imported Fire Ants, Solenopsis invicta Buren (Hymenoptera: Formicidae), in Taiwan. Environmental Entomology. 2006;35(1):167-172.
17.Golden DB, Demain J, Freeman T, et al. Stinging insect hypersensitivity: A practice parameter update 2016. Ann Allergy Asthma Immunol. 2017;118(1):28-54.
18.JUN-ICHI KOJIMA FS, LIEN THI PHUONG NGUYEN. On the species-group taxa of Taiwanese social wasps (Hymenoptera: Vespidae) described and/or treated by J. Sonan. Zootaxa. 2011;2920:42-64.
19.Bresolin NL, Carvalho LC, Goes EC, Fernandes R, Barotto AM. Acute renal failure following massive attack by Africanized bee stings. Pediatr Nephrol. 2002;17(8):625-627.
20.Braun CT, Mikula M, Ricklin ME, Exadaktylos AK, Helbling A. Climate data, localisation of the sting, grade of anaphylaxis and therapy of hymenoptera stings. Swiss Med Wkly. 2016;146:w14272.
21.Caffier PP, Schrom T, Haupt H, Mazurek B. [Increasing incidence of wasp stings in otorhinolaryngological practice]. HNO. 2006;54(6):451-456.
22.Tracy JM, Demain JG, Quinn JM, Hoffman DR, Goetz DW, Freeman TM. The natural history of exposure to the imported fire ant (Solenopsis invicta). J Allergy Clin Immunol. 1995;95(4):824-828.
23.Yanagawa Y, Morita K, Sugiura T, Okada Y. Cutaneous hemorrhage or necrosis findings after Vespa mandarinia (wasp) stings may predict the occurrence of multiple organ injury: a case report and review of literature. Clinical toxicology (Philadelphia, Pa.). 2007;45(7):803-807.
24.Clark S, Long AA, Gaeta TJ, Camargo CA, Jr. Multicenter study of emergency department visits for insect sting allergies. J Allergy Clin Immunol. 2005;116(3):643-649.
25.Bilo MB, Pravettoni V, Bignardi D, et al. Hymenoptera Venom Allergy: Management of Children and Adults in Clinical Practice. J Investig Allergol Clin Immunol. 2019;29(3):180-205.
26.Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy. 2009;64(2):204-212.
27.Rudders SA, Banerji A, Katzman DP, Clark S, Camargo CA, Jr. Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department. Ann Allergy Asthma Immunol. 2010;105(1):85-93.
28.Valent P. Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders. Clin Exp Allergy. 2014;44(7):914-920.
29.Prince BT, Mikhail I, Stukus DR. Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities. Journal of asthma and allergy. 2018;11:143-151.
30.Simons FE, Ardusso LR, Bilo MB, et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol. 2011;127(3):587-593 e581-522.
31.Reisman RE. Insect stings. N Engl J Med. 1994;331(8):523-527.
32.Diaz JH. Recognition, management, and prevention of hymenopteran stings and allergic reactions in travelers. J Travel Med. 2009;16(5):357-364.
33.Bhatta N, Singh R, Sharma S, Sinnha A, Raja S. Acute renal failure following multiple wasp stings. Pediatr Nephrol. 2005;20(12):1809-1810.
34.Baer H, Liu TY, Anderson MC, Blum M, Schmid WH, James FJ. Protein components of fire ant venom (Solenopsis invicta). Toxicon. 1979;17(4):397-405.
35.Srisong H, Daduang S, Lopata AL. Current advances in ant venom proteins causing hypersensitivity reactions in the Asia-Pacific region. Molecular Immunology. 2016;69:24-32.
36.Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391-397.
37.Silva GBDJ, Vasconcelos AGJ, Rocha AMT, et al. Acute kidney injury complicating bee stings - a review. Revista do Instituto de Medicina Tropical de Sao Paulo. 2017;59:e25.
38.Xie C, Xu S, Ding F, et al. Clinical features of severe wasp sting patients with dominantly toxic reaction: analysis of 1091 cases. PLoS One. 2013;8(12):e83164.
39.Mingomataj EC, Bakiri AH, Ibranji A, Sturm GJ. Unusual reactions to hymenoptera stings: what should we keep in mind? Clin Rev Allergy Immunol. 2014;47(1):91-99.
40.Rajha E, Didi A, Dakik H, Mufarrij A. Acute ST elevation myocardial infarction due to allergic reaction, Kounis syndrome: A case report and review of the emergency management. The American journal of emergency medicine. 2019.
41.Urushidani S, Kuriyama A. A potential association between myocardial ischemia and epinephrine for anaphylaxis: A case report and literature review. The American journal of emergency medicine. 2020.
42.Kulhari A, Rogers A, Wang H, Kumaraswamy VM, Xiong W, DeGeorgia M. Ischemic Stroke After Wasp Sting. The Journal of emergency medicine. 2016;51(4):405-410.
43.Dalugama C, Gawarammana IB. Ischemic stroke following a wasp sting - a rare complication: a case report. Journal of medical case reports. 2018;12(1):294.
44.Ittyachen AM, Abdulla S, Anwarsha RF, Kumar BS. Multi-organ dysfunction secondary to severe wasp envenomation. Int J Emerg Med. 2015;8:6-6.
45.Prahlow JA, Barnard JJ. Fatal anaphylaxis due to fire ant stings. Am J Forensic Med Pathol. 1998;19(2):137-142.
46.Fernandez-Melendez S, Miranda A, Garcia-Gonzalez JJ, Barber D, Lombardero M. Anaphylaxis caused by imported red fire ant stings in Malaga, Spain. J Investig Allergol Clin Immunol. 2007;17(1):48-49.
47.Rupp MR, deShazo RD. Indoor fire ant sting attacks: a risk for frail elders. Am J Med Sci. 2006;331(3):134-138.
48.More DR, Kohlmeier RE, Hoffman DR. Fatal anaphylaxis to indoor native fire ant stings in an infant. Am J Forensic Med Pathol. 2008;29(1):62-63.
49.Yu JE, Lin RY. The Epidemiology of Anaphylaxis. Clinical Reviews in Allergy & Immunology. 2018;54(3):366-374.
50.Yao TC, Wu AC, Huang YW, Wang JY, Tsai HJ. Increasing trends of anaphylaxis-related events: an analysis of anaphylaxis using nationwide data in Taiwan, 2001-2013. World Allergy Organ J. 2018;11(1):23.
51.Motosue MS, Bellolio MF, Van Houten HK, Shah ND, Campbell RL. Increasing Emergency Department Visits for Anaphylaxis, 2005-2014. J Allergy Clin Immunol Pract. 2017;5(1):171-175.e173.
52.Motosue MS, Bellolio MF, Van Houten HK, Shah ND, Li JT, Campbell RL. Outcomes of Emergency Department Anaphylaxis Visits from 2005 to 2014. J Allergy Clin Immunol Pract. 2018;6(3):1002-1009.e1002.
53.Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026-1045.
54.Simons FER, Ardusso LRF, Bilò MB, et al. International consensus on (ICON) anaphylaxis. World Allergy Organization Journal. 2014;7:9.
55.Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30(8):1144-1150.
56.Lin Y-Y, Chiu C-C, Chang H-A, Kao Y-H, Hsiao P-J, Chuu C-P. Comparison of Clinical Manifestations, Treatments, and Outcomes between Vespidae Sting and Formicidae Sting Patients in the Emergency Department in Taiwan. International Journal of Environmental Research and Public Health. 2020;17(17):6162.
57.Ko BS, Kim JY, Seo DW, et al. Should adrenaline be used in patients with hemodynamically stable anaphylaxis? Incident case control study nested within a retrospective cohort study. Sci Rep. 2016;6:20168.
58.Droste J, Narayan N. Anaphylaxis: lack of hospital doctors′ knowledge of adrenaline (epinephrine) administration in adults could endanger patients′ safety. Eur Ann Allergy Clin Immunol. 2012;44(3):122-127.
59.Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol. 2010;10(4):354-361.
60.Tejedor-Alonso MA, Moro-Moro M, Múgica-García MV. Epidemiology of Anaphylaxis: Contributions From the Last 10 Years. J Investig Allergol Clin Immunol. 2015;25(3):163-175; quiz follow 174-165.
61.Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal Anaphylaxis: Mortality Rate and Risk Factors. J Allergy Clin Immunol Pract. 2017;5(5):1169-1178.
62.Lieberman P, Camargo CA, Jr., Bohlke K, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol. 2006;97(5):596-602.
63.Panesar SS, Javad S, de Silva D, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68(11):1353-1361.
64.Lin YY, Chiu CC, Chang HA, Kao YH, Hsiao PJ, Chuu CP. Comparison of Clinical Manifestations, Treatments, and Outcomes between Vespidae Sting and Formicidae Sting Patients in the Emergency Department in Taiwan. Int J Environ Res Public Health. 2020;17(17).
65.Dillman JR, Strouse PJ, Ellis JH, Cohan RH, Jan SC. Incidence and Severity of Acute Allergic-Like Reactions to IV Nonionic Iodinated Contrast Material in Children. American Journal of Roentgenology. 2007;188(6):1643-1647.
66.Long B, Gottlieb M. Emergency medicine updates: Anaphylaxis. The American journal of emergency medicine. 2021;49:35-39.
67.Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Journal of Allergy and Clinical Immunology. 2006;117(2):391-397.
68.Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114(2):371-376.
69.Cardona V, Ansotegui IJ, Ebisawa M, et al. World Allergy Organization Anaphylaxis Guidance 2020. World Allergy Organization Journal. 2020;13(10):100472.
70.Turner PJ, Worm M, Ansotegui IJ, et al. Time to revisit the definition and clinical criteria for anaphylaxis? World Allergy Organization Journal. 2019;12(10):100066.
71.Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis--a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341-384.
72.Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol. 2007;98(3):252-257.
73.Lee S, Hess EP, Nestler DM, et al. Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis. J Allergy Clin Immunol. 2013;131(4):1103-1108.
74.Brown SGA, Mullins RJ, Gold MS. 2. Anaphylaxis: diagnosis and management. Medical Journal of Australia. 2006;185(5):283-289.
75.Irani AM, Akl EG. Management and Prevention of Anaphylaxis. F1000Research. 2015;4.
76.Lieberman PL. Recognition and first-line treatment of anaphylaxis. The American journal of medicine. 2014;127(1 Suppl):S6-11.
77.Campbell RL, Bellolio MF, Knutson BD, et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract. 2015;3(1):76-80.
78.Kawano T, Scheuermeyer FX, Stenstrom R, Rowe BH, Grafstein E, Grunau B. Epinephrine use in older patients with anaphylaxis: Clinical outcomes and cardiovascular complications. Resuscitation. 2017;112:53-58.
79.McLean-Tooke AP, Bethune CA, Fay AC, Spickett GP. Adrenaline in the treatment of anaphylaxis: what is the evidence? Bmj. 2003;327(7427):1332-1335.
80.Kemp SF, Lockey RF, Simons FER, World Allergy Organization ad hoc Committee on Epinephrine in A. Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization. World Allergy Organ J. 2008;1(7 Suppl):S18-S26.
81.Kounis NG. Coronary hypersensitivity disorder: the Kounis syndrome. Clin Ther. 2013;35(5):563-571.
82.Fineman SM. Optimal Treatment of Anaphylaxis: Antihistamines Versus Epinephrine. Postgraduate Medicine. 2014;126(4):73-81.
83.Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2007;62(8):830-837.
84.Choo KJ, Simons FE, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Evidence-based child health : a Cochrane review journal. 2013;8(4):1276-1294.
85.Grunau BE, Wiens MO, Rowe BH, et al. Emergency Department Corticosteroid Use for Allergy or Anaphylaxis Is Not Associated With Decreased Relapses. Ann Emerg Med. 2015;66(4):381-389.
86.Dewachter P, Mouton-Faivre C, Emala CW. Anaphylaxis and anesthesia: controversies and new insights. Anesthesiology. 2009;111(5):1141-1150.
87.Campbell RL, Li JT, Nicklas RA, Sadosty AT. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol. 2014;113(6):599-608.
88.Dodd A, Hughes A, Sargant N, Whyte AF, Soar J, Turner PJ. Evidence update for the treatment of anaphylaxis. Resuscitation. 2021;163:86-96.
89.Alvarez-Perea A, Tanno LK, Baeza ML. How to manage anaphylaxis in primary care. Clin Transl Allergy. 2017;7:45.
90.Seak C-J, Fang C-C. Celebrating the 20th Anniversary of Emergency Medicine Specialty in Taiwan. J Acute Med. 2018;8(1):1-5.
91.Long BJ, Koyfman A, Gottlieb M. Evaluation and Management of Angioedema in the Emergency Department. West J Emerg Med. 2019;20(4):587-600.
92.D′Amato G, Vitale C, Lanza M, et al. Near fatal asthma: treatment and prevention. Eur Ann Allergy Clin Immunol. 2016;48(4):116-122.
93.Ring J, Beyer K, Biedermann T, et al. Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB). Allergo J Int. 2014;23(3):96-112.
94.Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol. 2005;5(4):359-364.
95.Geerts BF, van den Bergh L, Stijnen T, Aarts LP, Jansen JR. Comprehensive review: is it better to use the Trendelenburg position or passive leg raising for the initial treatment of hypovolemia? J Clin Anesth. 2012;24(8):668-674.
96.Rich K. Trendelenburg position in hypovolemic shock: A review. Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing. 2019;37(1):71-73.
97.Brown SG, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emergency medicine journal : EMJ. 2004;21(2):149-154.
98.Soar J, Pumphrey R, Cant A, et al. Emergency treatment of anaphylactic reactions--guidelines for healthcare providers. Resuscitation. 2008;77(2):157-169.
99.Stellpflug C, Pierson L, Roloff D, et al. Continuous Physiological Monitoring Improves Patient Outcomes. The American journal of nursing. 2021;121(4):40-46.
100.Cardona-Morrell M, Prgomet M, Turner RM, Nicholson M, Hillman K. Effectiveness of continuous or intermittent vital signs monitoring in preventing adverse events on general wards: a systematic review and meta-analysis. Int J Clin Pract. 2016;70(10):806-824.
101.Mok WQ, Wang W, Liaw SY. Vital signs monitoring to detect patient deterioration: An integrative literature review. International journal of nursing practice. 2015;21 Suppl 2:91-98.
102.Pimentel-Hayashi JA, Navarrete-Rodriguez EM, Moreno-Laflor OI, Del Rio-Navarro BE. Physicians′ knowledge regarding epinephrine underuse in anaphylaxis. Asia Pacific allergy. 2020;10(4):e40.
103.Fergeson JE, Patel SS, Lockey RF. Acute asthma, prognosis, and treatment. J Allergy Clin Immunol. 2017;139(2):438-447.
104.U.S. Department of Health and Human Services, National Institutes of Health [Internet]. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (EPR-3). 2007 Jul [cited 2013 Jan 22]. ; http://www.nhlbi.nih.gov/health-pro/guidelines/current/asthma-guidelines, 2007
105.Hernandez L, Papalia S, Pujalte GG. Anaphylaxis. Primary care. 2016;43(3):477-485.
106.Tanno LK, Gonzalez-Estrada A, Olivieri B, Caminati M. Asthma and anaphylaxis. Curr Opin Allergy Clin Immunol. 2019;19(5):447-455.
107.Smith D, Riel J, Tilles I, Kino R, Lis J, Hoffman JR. Intravenous epinephrine in life-threatening asthma. Ann Emerg Med. 2003;41(5):706-711.
108.De Backer D, Foulon P. Minimizing catecholamines and optimizing perfusion. Critical care (London, England). 2019;23(Suppl 1):149.
109.Sharma S, Hashmi MF, Bhattacharya PT. Hypotension. StatPearls. Treasure Island (FL): StatPearls Publishing
Copyright © 2021, StatPearls Publishing LLC.; 2021.
110.J MD, Anosike K, Waseem M. Permissive Hypotension. StatPearls. Treasure Island (FL): StatPearls Publishing
Copyright © 2021, StatPearls Publishing LLC.; 2021.
111.Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082-1123.
112.Manivannan V, Hess EP, Bellamkonda VR, et al. A multifaceted intervention for patients with anaphylaxis increases epinephrine use in adult emergency department. J Allergy Clin Immunol Pract. 2014;2(3):294-299.e291.
113.Pourmand A, Robinson C, Syed W, Mazer-Amirshahi M. Biphasic anaphylaxis: A review of the literature and implications for emergency management. The American journal of emergency medicine. 2018;36(8):1480-1485.
114.Lee S, Peterson A, Lohse CM, Hess EP, Campbell RL. Further Evaluation of Factors That May Predict Biphasic Reactions in Emergency Department Anaphylaxis Patients. J Allergy Clin Immunol Pract. 2017;5(5):1295-1301.
115.Grunau BE, Li J, Yi TW, et al. Incidence of clinically important biphasic reactions in emergency department patients with allergic reactions or anaphylaxis. Ann Emerg Med. 2014;63(6):736-744.e732.
116.Sundquist BK, Jose J, Pauze D, Pauze D, Wang H, Järvinen KM. Anaphylaxis risk factors for hospitalization and intensive care: A comparison between adults and children in an upstate New York emergency department. Allergy Asthma Proc. 2019;40(1):41-47.
117.Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327(6):380-384.
118.Shen Y, Li L, Grant J, et al. Anaphylactic deaths in Maryland (United States) and Shanghai (China): a review of forensic autopsy cases from 2004 to 2006. Forensic science international. 2009;186(1-3):1-5.
119.Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol. 2004;4(4):285-290.
120.Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365(9470):1577-1589.
121.Trollope A, Moxon JV, Moran CS, Golledge J. Animal models of abdominal aortic aneurysm and their role in furthering management of human disease. Cardiovasc Pathol. 2011;20(2):114-123.
122.Sidloff D, Stather P, Dattani N, et al. Aneurysm global epidemiology study: public health measures can further reduce abdominal aortic aneurysm mortality. Circulation. 2014;129(7):747-753.
123.Baxter BT, Terrin MC, Dalman RL. Medical management of small abdominal aortic aneurysms. Circulation. 2008;117(14):1883-1889.
124.Ailawadi G, Eliason JL, Upchurch GR, Jr. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg. 2003;38(3):584-588.
125.Burdock GA. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol. 1998;36(4):347-363.
126.Natarajan K, Singh S, Burke TR, Jr., Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci U S A. 1996;93(17):9090-9095.
127.Ma Z, Wei X, Fontanilla C, et al. Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicity. Life Sci. 2006;79(13):1307-1311.
128.Song JJ, Lim HW, Kim K, Kim KM, Cho S, Chae SW. Effect of caffeic acid phenethyl ester (CAPE) on H(2)O(2) induced oxidative and inflammatory responses in human middle ear epithelial cells. Int J Pediatr Otorhinolaryngol. 2012;76(5):675-679.
129.Michaluart P, Masferrer JL, Carothers AM, et al. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res. 1999;59(10):2347-2352.
130.Hassan NA, El-Bassossy HM, Mahmoud MF, Fahmy A. Caffeic acid phenethyl ester, a 5-lipoxygenase enzyme inhibitor, alleviates diabetic atherosclerotic manifestations: effect on vascular reactivity and stiffness. Chem Biol Interact. 2014;213:28-36.
131.Sciences NAPUNAo. National Research Council Committee for the Update of the Guide for the, C. & Use of Laboratory, A. In Guide for the Care and Use
of Laboratory Animals2011.
132.Tian ZH, Weng JT, Shih LJ, et al. Arecoline inhibits the growth of 3T3-L1 preadipocytes via AMP-activated protein kinase and reactive oxygen species pathways. PLoS One. 2018;13(7):e0200508.
133.Shih L-J, Lin Y-R, Lin C-K, Liu H-S, Kao Y-H. Green tea (-)-epigallocatechin gallate induced growth inhibition of human placental choriocarcinoma cells. Placenta. 2016;41:1-9.
134.Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. The Journal of clinical investigation. 2000;105(11):1605-1612.
135.Ernst CB. Abdominal aortic aneurysm. N Engl J Med. 1993;328(16):1167-1172.
136.Thompson RW, Curci JA, Ennis TL, Mao D, Pagano MB, Pham CT. Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds. Ann N Y Acad Sci. 2006;1085:59-73.
137.Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2006;26(5):987-994.
138.Mata KM, Prudente PS, Rocha FS, et al. Combining two potential causes of metalloproteinase secretion causes abdominal aortic aneurysms in rats: a new experimental model. Int J Exp Pathol. 2011;92(1):26-39.
139.Liapis CD, Paraskevas KI. The pivotal role of matrix metalloproteinases in the development of human abdominal aortic aneurysms. Vasc Med. 2003;8(4):267-271.
140.Daugherty A, Cassis LA, Lu H. Complex pathologies of angiotensin II-induced abdominal aortic aneurysms. J Zhejiang Univ Sci B. 2011;12(8):624-628.
141.Lo Sasso G, Schlage WK, Boué S, Veljkovic E, Peitsch MC, Hoeng J. The Apoe(-/-) mouse model: a suitable model to study cardiovascular and respiratory diseases in the context of cigarette smoke exposure and harm reduction. J Transl Med. 2016;14(1):146-146.
142.Yamanouchi D, Morgan S, Kato K, Lengfeld J, Zhang F, Liu B. Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2010;30(4):702-707.
143.Lacolley P, Regnault V, Nicoletti A, Li Z, Michel JB. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res. 2012;95(2):194-204.
144.Gomez D, Owens GK. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res. 2012;95(2):156-164.
145.Mao N, Gu T, Shi E, Zhang G, Yu L, Wang C. Phenotypic switching of vascular smooth muscle cells in animal model of rat thoracic aortic aneurysm. Interact Cardiovasc Thorac Surg. 2015;21(1):62-70.
146.Peshkova IO, Schaefer G, Koltsova EK. Atherosclerosis and aortic aneurysm - is inflammation a common denominator? The FEBS journal. 2016;283(9):1636-1652.
147.Airhart N, Brownstein BH, Cobb JP, et al. Smooth muscle cells from abdominal aortic aneurysms are unique and can independently and synergistically degrade insoluble elastin. J Vasc Surg. 2014;60(4):1033-1041; discussion 1041-1032.
148.Ghosh A, DiMusto PD, Ehrlichman LK, et al. The role of extracellular signal-related kinase during abdominal aortic aneurysm formation. J Am Coll Surg. 2012;215(5):668-680.e661.
149.Tian X, Fan J, Yu M, et al. Adipose stem cells promote smooth muscle cells to secrete elastin in rat abdominal aortic aneurysm. PLoS One. 2014;9(9):e108105.
150.Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Molecular cancer. 2013;12:86. |